Choosing the right digital patient support platform is an important decision for pharmaceutical manufacturers, particularly those managing specialty and complex therapies.
These treatments often require more than patient education and medication reminders. Patients may need support navigating enrollment, treatment initiation, laboratory monitoring, specialty pharmacy coordination, and long-term adherence.
For pharmaceutical leaders, the challenge is finding a platform that connects these activities rather than managing them in isolation. Disconnected workflows can create delays, limit visibility, and make it harder to identify when patients need additional support.
This is where connected patient support infrastructure becomes essential. RxPx takes this approach by bringing together technology, strategy, implementation, and human support to help pharmaceutical manufacturers coordinate the treatment journey.
Ultimately, the question isn’t simply which platform offers the most features. It’s which one can support the clinical, operational, and commercial complexity of a therapy at scale.
What Is the Best Patient Support Platform for Large Pharma Companies?
The best patient support platform for large pharmaceutical companies is one that combines scalable technology, connected patient services, integrated safety workflows, actionable data, and human support within a secure, governed infrastructure.
For specialty and complex therapies, an effective platform should help manufacturers:
- Coordinate patients, healthcare professionals (HCPs), laboratories, pharmacies, and support teams.
- Reduce friction between prescribing and treatment initiation.
- Identify adherence barriers and potential safety risks earlier.
- Support therapy-specific clinical and operational requirements.
- Measure patient engagement and program performance.
- Scale across brands, therapeutic areas, and markets.
The strongest solutions go beyond digitizing individual tasks. They connect the workflows that influence whether patients can start, stay on, and succeed with treatment.
Seven Criteria for Evaluating Digital Patient Support Platforms
When comparing digital patient support platforms, pharmaceutical manufacturers should focus on seven core capabilities.
1. Connected Patient Journeys
Patient support rarely happens in one system.
Enrollment, consent, prescription coordination, pharmacy fulfillment, monitoring, and ongoing support may involve different teams and providers.
When these processes are disconnected, patients can experience unnecessary delays, repeated administrative steps, and gaps in communication.
A comprehensive platform should coordinate these activities through connected workflows, giving stakeholders greater visibility into what needs to happen next.
Ask vendors: Can your platform connect the full patient journey, or does it support only individual activities?
2. Therapy-Specific Flexibility
Not every therapy requires the same support model.
An oncology treatment with complex monitoring requirements may need different workflows from a chronic specialty therapy focused on long-term adherence.
The FDA’s Patient-Focused Drug Development guidance emphasizes systematically understanding patients’ experiences and what matters to them during treatment. Although developed for medical product development, this patient-centered principle is also relevant when designing support programs.
Large pharmaceutical companies should look for platforms that can adapt to different patient populations, clinical protocols, and therapeutic requirements without rebuilding the entire program.
Ask vendors: How easily can your platform accommodate different therapeutic areas, clinical requirements, and patient support models?
3. Integrated Safety Monitoring
For complex therapies, patient support and safety monitoring often need to work together.
Some treatments require laboratory testing, symptom tracking, scheduled assessments, or defined escalation procedures.
A digital patient support platform should be able to support these activities through appropriate monitoring workflows, alerts, documentation, and human oversight.
For example, RxPx’s Complex Safety Monitoring solution integrates laboratory monitoring, alert routing, and appropriate escalation processes into broader patient support workflows.
Ask vendors: How does your platform support therapy-specific monitoring, potential safety signals, and escalation requirements?
4. Proactive Adherence and Engagement
Medication reminders and educational resources are useful, but they don’t always address why patients disengage.
The World Health Organization’s Adherence to Long-Term Therapies: Evidence for Action identifies adherence as a multidimensional challenge influenced by patient, therapy, condition, healthcare system, and socioeconomic factors.
For specialty therapy support programs, this reinforces the importance of understanding the barriers behind patient behavior rather than relying solely on reminders.
A missed dose may be related to side effects, treatment concerns, access barriers, or personal circumstances.
Effective support requires combining digital engagement capabilities with patient insights and human intervention.
Knowing a dose was missed matters. Understanding why matters more.
Ask vendors: Can your platform identify potential adherence risks and trigger appropriate follow-up before patients disengage?
5. Actionable Data and Performance Visibility
Collecting patient engagement data is only valuable if it helps teams make better decisions.
Pharmaceutical manufacturers need visibility into what is happening across their programs, including enrollment progression, treatment initiation, engagement patterns, and operational barriers.
The right platform should help teams identify where patients encounter difficulties and where support processes may need improvement.
This visibility should operate within appropriate privacy, consent, and data governance requirements.
Ask vendors: Can your platform identify where patients are struggling and provide actionable insights to improve digital patient support program performance?
6. Enterprise Scalability and Governance
Security, patient safety, and regulatory compliance are essential for every pharmaceutical patient support program, regardless of size.
For large pharmaceutical organizations, the additional challenge is maintaining these standards while scaling across multiple brands, therapeutic areas, and markets.
Digital patient support platforms should provide secure data management, integration capabilities, defined governance processes, and the flexibility to support complex workflows at scale.
For platforms incorporating artificial intelligence, the NIST AI Risk Management Framework provides a useful reference for evaluating AI governance, risk management, and trustworthiness.
Ask vendors: Can your platform scale across brands and markets while maintaining consistent security, regulatory compliance, and governance?
7. Human Support and Continuous Optimization
Technology can identify a potential problem, but it doesn’t always resolve it.
A patient experiencing treatment anxiety may need a conversation with a trained support professional. An enrollment delay may require coordination between multiple stakeholders.
The strongest patient support models combine technology with human expertise to address these situations.
They also evolve over time, using program insights to refine workflows, engagement strategies, and support services.
Ask vendors: How do your technology and service teams work together to address patient barriers and improve program performance over time?
Digital Patient Support Platform Evaluation Checklist
Choosing the right digital patient support platform requires looking beyond individual features to understand how effectively a solution supports the full patient journey.
For pharmaceutical manufacturers evaluating specialty therapy support programs, these seven criteria provide a practical framework for comparing potential partners.
| Evaluation Area | What to Look For |
| Patient Journey Coordination | Connected workflows from enrollment and treatment initiation through ongoing patient support. |
| Therapy-Specific Flexibility | Configurable pathways that accommodate different therapies, patient populations, and clinical requirements. |
| Safety Integration | Monitoring capabilities, defined escalation workflows, human oversight, and audit-ready documentation. |
| Adherence and Engagement | Proactive identification of patient barriers and timely, personalized interventions. |
| Performance Visibility | Actionable insights into treatment initiation, engagement, adherence, and operational performance. |
| Enterprise Scalability | Security, governance, interoperability, and the ability to support multiple brands and markets. |
| Human Support | Coordinated digital and human-led services, with continuous program optimization. |
The right platform will depend on the therapy’s complexity, patient population, and commercial objectives. For specialty and complex therapies, manufacturers should prioritize solutions that connect these capabilities rather than managing them as separate services.
Common Mistakes When Selecting a Pharma Patient Support Platform
Even well-designed programs can underperform when platform selection focuses on technology rather than the broader patient journey.
Three common mistakes include:
Choosing features instead of connected workflows. A long list of capabilities doesn’t guarantee that information, responsibilities, and next steps move efficiently between stakeholders.
Treating patient support as separate from clinical and operational requirements. For complex therapies, treatment access, safety monitoring, adherence, and HCP coordination are closely connected.
Focusing on launch without planning for long-term performance. A platform should support more than initial enrollment. It should help manufacturers understand and respond to patient needs throughout the treatment lifecycle.
Avoiding these mistakes starts with identifying the risks and barriers specific to a therapy before selecting the technology intended to address them.
How Should Pharma Measure Patient Support Platform Performance?
Selecting a platform is only the beginning. Pharmaceutical manufacturers also need to understand whether it is delivering meaningful results.
Key performance indicators may include:
- Time to treatment: How efficiently patients move from prescribing or enrollment to treatment initiation.
- Patient engagement: Whether patients participate in relevant support activities.
- Adherence and persistence: Whether patients follow treatment regimens and remain on therapy where clinically appropriate.
- Operational efficiency: Where delays, duplication, or disconnected hand-offs occur.
- Safety workflow performance: Whether monitoring requirements and escalation processes are completed appropriately.
The most valuable insights help manufacturers understand not just what happened, but where intervention or program improvement may be needed.
Building Connected Patient Support Infrastructure
For specialty and complex therapies, effective patient support requires more than technology. It requires connected infrastructure that brings patients, HCPs, laboratories, pharmacies, and support teams together.
As an infrastructure partner to pharmaceutical manufacturers, RxPx combines strategy, technology, implementation, and human support to coordinate patient engagement, adherence, safety monitoring, and ongoing care.
This connected approach helps manufacturers reduce fragmentation, identify risks earlier, and improve visibility across the treatment journey.
Choosing the right digital patient support platform starts with understanding the unique challenges of your therapy.
Book a Brand Risk Assessment to explore how RxPx can help identify potential risks and build the infrastructure needed to address them.
